Quick Answer
ABEONA THERAPEUTICS INC. reported Cash and Equivalents of $78.44 million for fiscal year 2025.
ABEONA THERAPEUTICS INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $78.44M | +235.8% |
| 2024 | $23.36M | +61.4% |
| 2023 | $14.47M | +1.8% |
| 2022 | $14.22M | -56.8% |
| 2021 | $32.94M | +161.5% |
| 2020 | $12.60M | -90.3% |
| 2019 | $129.26M | +589.4% |
| 2018 | $18.75M | -86.4% |
| 2017 | $137.75M | +99.2% |
| 2016 | $69.14M | +72.3% |
| 2015 | $40.14M | +248.4% |
| 2014 | $11.52M | +2617.0% |
| 2013 | $424.0K | +7.1% |
| 2012 | $396.0K | -83.9% |
| 2011 | $2.46M | -65.0% |
| 2010 | $7.03M | +1058.6% |
| 2009 | $607.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $82.88M | +427.1% | -49.3% |
| June 30, 2025 | $163.53M | +375.0% | +926.2% |
| March 31, 2025 | $15.94M | -9.2% | -31.8% |
| December 31, 2024 | $23.36M | +61.4% | +48.5% |
| September 30, 2024 | $15.73M | +233.7% | -54.3% |
| June 30, 2024 | $34.43M | +453.0% | +96.1% |
| March 31, 2024 | $17.56M | +275.2% | +21.3% |
| December 31, 2023 | $14.47M | +1.8% | +207.2% |
- ABEONA THERAPEUTICS INC. showed an increase of +235.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2025 period, ABEONA THERAPEUTICS INC.’s cash and equivalents has grown by 12822.1% (from $607.0 thousand to $78.44 million).
- The most recent figure is from ABEONA THERAPEUTICS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: